The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
NU HLDGS LTD ORD SHS CL A G6683N103   14,663,178 1,431,951 SH   SOLE   1,431,951 0 0
AKERO THERAPEUTICS INC COM 00973Y108   13,297,842 328,504 SH   SOLE   328,504 0 0
89BIO INC COM 282559103   8,384,905 1,153,357 SH   SOLE   1,153,357 0 0
ISHARES TR CORE S&P500 ETF 464287200   7,054,655 12,555 SH   SOLE   12,555 0 0
MADRIGAL PHARMACEUTICALS INC COM 558868105   16,023,582 48,376 SH   SOLE   48,376 0 0
PEARL DIVER CREDIT COMPANY I COM SHS 70476Q100   27,623,054 1,459,221 SH   SOLE   1,459,221 0 0
SAREPTA THERAPEUTICS INC COM 803607100   1,768,899 27,717 SH   SOLE   27,717 0 0
SEA LTD SPONSORD ADS 81141R100   29,026,086 307,504 SH   SOLE   307,504 0 0